함께 비교하는 진짜 ADC · Antibody · CGT 데이터

CGTBiologicstaleThe First Affiliated Hospital o…Phase 1

JWCAR129 (JWCAR129)

Safety and Efficacy · Safety and Efficacy

#SafetyandEfficacy#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleNelson HamerschlakPhase 1

Chimeric antigen receptor T cells to be implemented in a "3 + 3" design on day 0 (Chimeric antigen receptor T cells to be implemented in a "3 + 3" design on day 0)

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia Refractory · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5

AntibodystaleInnoventPreclinical

Sintilimab ，bevcizumab/cetuximab，XELOX (Sintilimab ，bevcizumab/cetuximab，XELOX)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Preclinical#항체#면역항체+2

AntibodystaleJanssenPhase 3

Infliximab at weeks 0 and 8 (Infliximab at weeks 0 and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2

ADCBiologicstaleImmunoGen, Inc.Phase 1

IMGN289 (IMGN289)

EGFR Positive Solid Tumors · EGFR

#EGFR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleGilead SciencesPhase 2

IMMU-132 infusion is administered to participants in one arm for the study (IMMU-132 infusion is administered to participants in one arm for the study)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleCartesian TherapeuticsPhase 3

Decartes-08 (Decartes-08)

Myasthaenia Gravis · Myasthaenia Gravis

#MyasthaeniaGravis#CGT#Phase3#세포유전치료#CAR-T+2

CGTBiologicstaleXinqiao Hospital of ChongqingPhase 1

in vivo CAR-T drug based on LNP-mRNA (in vivo CAR-T drug based on LNP-mRNA)

Autoimmune Diseases · B-cell Malignancies

#B-cellMalignancies#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleSheba Medical CenterPhase 3

CAR-T CD19 (CAR-T CD19)

Acute Myeloid Leukemia · CD19

#CD19#CGT#Phase3#세포유전치료#CAR-T+3

효능 ORR 67%임상시험 1상태 ACTIVE

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

FGFR4-CAR T Cells (FGFR4-CAR T Cells)

Rhabdomyosarcoma · Rhabdomyosarcoma

#Rhabdomyosarcoma#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleGary Archer Ph.D.Phase 1

EGFRvIII-CARs (EGFRvIII-CARs)

Recurrent Glioblastoma; Recurrent Gliosarcoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4

효능 ORR 0%임상시험 1상태 DISCONTINUED

AntibodystaleJanssenPhase 3

Infliximab and methotrexate (Infliximab and methotrexate)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#항체#면역항체+2

CGTBiologicstaleVor BiopharmaPhase 2

VCAR33 (VCAR33)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#CGT#Phase2#세포유전치료#CAR-T+5

CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM19 CAR-T (IM19 CAR-T)

Hematological Malignancies · Leukemia

#Leukemia#CGT#Phase1#세포유전치료#CAR-T+3

AntibodystaleJanssenApproved

Infliximab and MTX (Infliximab and MTX)

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Approved#항체#면역항체+2

AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody (Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3

AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab and Relatlimab)

Metastatic Melanoma; Liver Metastases · Metastatic Melanoma

#MetastaticMelanoma#Antibody#Phase2#항체#면역항체+3

AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Rucaparib and Nivolumab)

Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2

효능 ORR 4%임상시험 1상태 ACTIVE

AntibodystaleJanssenApproved

Infliximab CT-P13 (Infliximab CT-P13)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2

AntibodystaleJanssenPhase 3

Infliximab at weeks 0,4, and 8 (Infliximab at weeks 0,4, and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2

AntibodystaleEli LillyPhase 2

Cetuximab Radioimmunotherapy (Cetuximab Radioimmunotherapy)

Squamous Cell Carcinoma of the Hypopharynx Stage III; Squamous Cell Carcinoma of the Hypopharynx Stage IV · Squamous Cell Carcinoma of the Hypophary

#SquamousCellCarcinomaoftheHypoph#Antibody#Phase2#항체#면역항체+2

CGTBiologicstaleBeijing GoBroad HospitalPhase 2

umbilical cord blood CD19-BCMA CAR-T cells infusion (umbilical cord blood CD19-BCMA CAR-T cells infusion)

Refractory Lupus Nephritis; Systemic Sclerosis · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleFred Hutchinson Cancer CenterPhase 1

FOLR1 CAR T-cells (FOLR1 CAR T-cells)

Recurrent Childhood Acute Myeloid Leukemia; Refractory Childhood Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

효능 ORR 0%임상시험 1상태 RECRUITING

CGTBiologicstaleBioray LaboratoriesPreclinical

BCMA-UCART (BCMA-UCART)

Multiple Myeloma · BCMA

#BCMA#CGT#Preclinical#세포유전치료#CAR-T+3